{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:12:34Z","timestamp":1795111954915,"version":"4.10.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA34944"],"award-info":[{"award-number":["CA34944"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA40360"],"award-info":[{"award-number":["CA40360"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA167552"],"award-info":[{"award-number":["CA167552"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 CA167552"],"award-info":[{"award-number":["UM1 CA167552"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA141298"],"award-info":[{"award-number":["CA141298"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL26490"],"award-info":[{"award-number":["HL26490"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL34595"],"award-info":[{"award-number":["HL34595"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.euo.2018.07.002","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T10:28:03Z","timestamp":1533032883000},"page":"126-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study"],"prefix":"10.1016","volume":"2","author":[{"given":"Mary K.","family":"Downer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Allard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey A.","family":"Kenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorelei A.","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Giovannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir J.","family":"Stampfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2018.07.002_bib0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2018.07.002_bib0160","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","article-title":"Aspirin and cancer risk: a quantitative review to 2011","volume":"23","author":"Bosetti","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2018.07.002_bib0165","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","article-title":"Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement","volume":"150","author":"U.S. Preventive Services Task Force","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.euo.2018.07.002_bib0170","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/ijc.25186","article-title":"Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis","volume":"127","author":"Mahmud","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euo.2018.07.002_bib0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1741-7015-12-55","article-title":"Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.euo.2018.07.002_bib0180","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1158\/1078-0432.CCR-14-2235","article-title":"Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study","volume":"21","author":"Vidal","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2018.07.002_bib0185","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ejca.2015.02.003","article-title":"The risk of prostate cancer for men on aspirin, statin or antidiabetic medications","volume":"51","author":"Nordstrom","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euo.2018.07.002_bib0190","first-page":"33","article-title":"Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink","volume":"25","author":"Cardwell","year":"2014","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.euo.2018.07.002_bib0195","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.juro.2014.11.018","article-title":"The use of aspirin and the risk of mortality in patients with prostate cancer","volume":"193","author":"Assayag","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2018.07.002_bib0200","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/1940-6207.CAPR-17-0033","article-title":"Do aspirin and other NSAIDs confer a survival benefit in men diagnosed with prostate cancer?. A pooled analysis of NIH-AARP and PLCO cohorts","volume":"10","author":"Zhou","year":"2017","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.euo.2018.07.002_bib0205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/annonc\/mdt428","article-title":"A cohort study investigating aspirin use and survival in men with prostate cancer","volume":"25","author":"Flahavan","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2018.07.002_bib0210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2018.07.002_bib0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians\u2019 Health Study","volume":"321","author":"Steering Committee of the Physicians\u2019 Health Study Research Group","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2018.07.002_bib0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.euo.2018.07.002_bib0225","doi-asserted-by":"crossref","first-page":"E3053","DOI":"10.1073\/pnas.1411082111","article-title":"Platelets guide the formation of early metastatic niches","volume":"111","author":"Labelle","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euo.2018.07.002_bib0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2407-14-167","article-title":"Presence of intratumoral platelets is associated with tumor vessel structure and metastasis","volume":"14","author":"Li","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euo.2018.07.002_bib0235","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/s12885-015-1634-x","article-title":"Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion","volume":"15","author":"Cooke","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euo.2018.07.002_bib0240","doi-asserted-by":"crossref","first-page":"e26125","DOI":"10.1371\/journal.pone.0026125","article-title":"Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells","volume":"6","author":"Egan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2018.07.002_bib0245","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1464-410x.2000.00507.x","article-title":"The role of prostaglandin synthesis in prostate cancer","volume":"85","author":"Badawi","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2018.07.002_bib0250","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1572-0241.2002.05625.x","article-title":"Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer","volume":"97","author":"Zhang","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.euo.2018.07.002_bib0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2362.2007.01896.x","article-title":"Strong evidence for up-regulation of cyclooxygenase-1 in head and neck cancer","volume":"38","author":"Erovic","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.euo.2018.07.002_bib0260","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/ijc.29408","article-title":"The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the prostate-specific antigen-era","volume":"137","author":"Jahn","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euo.2018.07.002_bib0265","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2018.07.002_bib0270","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.eururo.2017.01.044","article-title":"Regular aspirin use and the risk of lethal prostate cancer in the Physicians\u2019 Health Study","volume":"72","author":"Downer","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2018.07.002_bib0275","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1200\/JCO.2013.54.8875","article-title":"Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer","volume":"32","author":"Jacobs","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2018.07.002_bib0280","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2011.41.0308","article-title":"Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy","volume":"30","author":"Choe","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2018.07.002_bib0285","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/1055-9965.EPI-16-1027","article-title":"Aspirin use reduces the risk of aggressive prostate cancer and disease recurrence in African-American men","volume":"26","author":"Smith","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euo.2018.07.002_bib0300","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1158\/1940-6207.CAPR-12-0171","article-title":"Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort","volume":"5","author":"Dhillon","year":"2012","journal-title":"Cancer Prev Res"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931118301044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931118301044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:44:45Z","timestamp":1762875885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931118301044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2588931118301044"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2018.07.002","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2018.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}